Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis

被引:88
|
作者
Mok, Chi Chiu [1 ]
Birmingham, Daniel J. [2 ]
Leung, Hoi Wah [1 ]
Hebert, Lee A. [2 ]
Song, Huijuan [2 ]
Rovin, Brad H. [2 ]
机构
[1] Tuen Mun Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Ohio State Univ, Med Ctr, Dept Med, Columbus, OH 43210 USA
关键词
vitamin D; atherosclerosis; cholecalciferol; disease activity; traditional risk factors; NUTRITION EXAMINATION SURVEY; 25-HYDROXYVITAMIN D LEVELS; D DEFICIENCY; CARDIOVASCULAR RISK; 1,25-DIHYDROXYVITAMIN D-3; AUTOIMMUNE-DISEASES; NATIONAL-HEALTH; D-RECEPTOR; SLE; PREVALENCE;
D O I
10.1093/rheumatology/ker212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To study the relationship of 25(OH)D-3 level with disease activity, vascular risk factors and atherosclerosis in SLE. Methods. Consecutive patients who fulfilled four or more ACR criteria for SLE were recruited for assay of 25(OH)D-3 level. Disease activity was assessed by the SLEDAI and physicians' global assessment (PGA). Patients with vascular risk factors were screened for atherosclerosis at the coronary or carotid arteries. Correlation between 25(OH)D-3 levels and SLEDAI scores was studied by linear regression. The link between vascular risk factors, atherosclerosis and vitamin D deficiency was also examined. Results. A total of 290 SLE patients were studied [94% women; mean (s.d.) age 38.9 (13.1) years; disease duration 7.7 (6.7) years; 78% patients had clinical or serological lupus activity]. Two hundred and seventy-seven (96%) patients had vitamin D insufficiency [25(OH)D-3 < 30 ng/ml] and 77 (27%) patients had vitamin D deficiency (< 15 ng/ml). Levels of 25(OH)D-3 correlated inversely with PGA (beta -0.20; P = 0.003), total SLEDAI scores (beta -0.19; P = 0.003) and subscores due to active renal, musculoskeletal and haematological disease. Subjects with vitamin D deficiency had significantly higher total/high-density lipoprotein (HDL) cholesterol ratio [3.96 (2.94) vs 3.07 (0.80); P = 0.02] and prevalence of aPLs (57 vs 39%; P = 0.007). Of 132 patients, 58 (44%) with vascular risk factors screened were positive for subclinical atherosclerosis. No association could be demonstrated between 25(OH)D-3 level and atherosclerosis, which was mainly associated with increasing age, menopause, obesity and hyper-triglyceridaemia. Conclusions. In this large cross-sectional study of SLE patients, 25(OH)D-3 level correlates inversely with disease activity. Vitamin D deficiency is associated with dyslipidaemia. In patients with vascular risk factors, subclinical atherosclerosis is not associated with hypovitaminosis D.
引用
收藏
页码:644 / 652
页数:9
相关论文
共 50 条
  • [31] Vitamin D and systemic lupus erythematosus: Causality and association with disease activity and therapeutics
    Ho, Ling-Jun
    Wu, Chien-Hsiang
    Luo, Shue-Fen
    Lai, Jenn-Haung
    BIOCHEMICAL PHARMACOLOGY, 2024, 227
  • [32] Current Daily Glucocorticoid Use and Serum Creatinine Levels Are Associated With Lower 25(OH) Vitamin D Levels in Thai Patients With Systemic Lupus Erythematosus
    Chaiamnuay, Sumapa
    Chailurkit, La-or
    Narongroeknawin, Pongthorn
    Asavatanabodee, Paijit
    Laohajaroensombat, Sukij
    Chaiamnuay, Pornthita
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2013, 19 (03) : 121 - 125
  • [33] Risk factors of disease activity and renal damage in patients with systemic lupus erythematosus
    Feng, Huiling
    Lu, Qianyu
    Liu, Yi
    Shi, Mengmeng
    Lian, Huan
    Ni, Lihua
    Wu, Xiaoyan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (12) : 3845 - 3855
  • [34] Subclinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indices
    Fadda, S.
    Nassar, H.
    Gamal, S. M.
    Al-azizi, H.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2015, 74 (06): : 529 - 532
  • [35] Vitamin D supplementation in systemic lupus erythematosus: relationship to disease activity, fatigue and the interferon signature gene expression
    Rosalie Magro
    Christian Saliba
    Liberato Camilleri
    Christian Scerri
    Andrew A. Borg
    BMC Rheumatology, 5
  • [36] Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus
    Kiss, Emese
    Seres, Ildiko
    Tarr, Tuende
    Kocsis, Zsolt
    Szegedi, Gyula
    Paragh, Gyoegy
    AUTOIMMUNITY, PT D: AUTOIMMUNE DISEASE, ANNUS MIRABILIS, 2007, 1108 : 83 - 91
  • [37] Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus
    Monticielo, Odirlei Andre
    Teixeira, Thaisa de Mattos
    Bogo Chies, Jose Artur
    Tavares Brenol, Joao Carlos
    Xavier, Ricardo Machado
    CLINICAL RHEUMATOLOGY, 2012, 31 (10) : 1411 - 1421
  • [38] Risk Factors for Clinical Coronary Heart Disease in Systemic Lupus Erythematosus: The Lupus and Atherosclerosis Evaluation of Risk (LASER) Study
    Haque, Sahena
    Gordon, Caroline
    Isenberg, David
    Rahman, Anisur
    Lanyon, Peter
    Bell, Aubrey
    Emery, Paul
    McHugh, Neil
    Teh, Lee Suan
    Scott, David G. I.
    Akil, Mohamed
    Naz, Sophia
    Andrews, Jacqueline
    Griffiths, Bridget
    Harris, Helen
    Youssef, Hazem
    McLaren, John
    Toescu, Veronica
    Devakumar, Vinodh
    Teir, Jamal
    Bruce, Ian N.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (02) : 322 - 329
  • [39] RETRACTED: The Effect of Vitamin D Supplementation on Inflammatory and Hemostatic Markers and Disease Activity in Patients with Systemic Lupus Erythematosus: A Randomized Placebo-controlled Trial (Retracted Article)
    Abou-Raya, Anna
    Abou-Raya, Suzan
    Helmii, Madihah
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (03) : 265 - 272
  • [40] The Impact of Vitamin D on the Immunopathophysiology, Disease Activity, and Extra-Musculoskeletal Manifestations of Systemic Lupus Erythematosus
    Mak, Anselm
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)